Cargando…

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study

PURPOSE: To create a predictive model of involuntary detrusor contraction (IDC) to improve the diagnostic accuracy of overactive detrusor (OAD), associating overactive bladder (OAB) symptoms with other clinical parameters in the female population. MATERIALS AND METHODS: A total of 727 women were stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arribillaga, Leandro Cristian, Ledesma, Marta, Montedoro, Ariel, Pisano, Florencia, Bengió, Rubén Guillermo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050563/ https://www.ncbi.nlm.nih.gov/pubmed/29211399 http://dx.doi.org/10.1590/S1677-5538.IBJU.2017.0213

Ejemplares similares

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer
por: Bengió, Rubén G., et al.
Publicado: (2018)

Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity
por: Fontaine, Christina L., et al.
Publicado: (2017)

Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters
por: Groenendijk, Ilse M., et al.
Publicado: (2019)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
por: Kaga, Kanya, et al.
Publicado: (2020)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?
por: Frankel, Jeffrey, et al.
Publicado: (2023)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
por: Jiang, Yuan-Hong, et al.
Publicado: (2023)

AB316. SPR-43 Comparison of bladder volumes between 2D and 3D ultrasound calculations and urodynamic measurements in women with overactive bladder (OAB)
por: Bernardo, Rachel J., et al.
Publicado: (2016)

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation
por: Oh, Jun Hyung, et al.
Publicado: (2010)

Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction
por: Yang, Tsai-Hwa, et al.
Publicado: (2018)

Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients—Preliminary Results
por: Schulte-Baukloh, Heinrich, et al.
Publicado: (2022)

Automated quantification of low amplitude rhythmic contractions (LARC) during real-world urodynamics identifies a potential detrusor overactivity subgroup
por: Cullingsworth, Zachary E., et al.
Publicado: (2018)

Efficacy, according to urodynamics, of OnabotulinumtoxinA compared with antimuscarinic drugs, for neurogenic detrusor overactivity: a systematic review and network meta-analysis
por: Xu, Rui, et al.
Publicado: (2022)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review
por: Khizer, Zara, et al.
Publicado: (2021)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
por: Bengió, Rubén G., et al.
Publicado: (2020)

Alterations of the Myovesical Plexus of the Human Overactive Detrusor
por: Kuijpers, Kamiel A. J., et al.
Publicado: (2014)

The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population
por: Lai, H. Henry, et al.
Publicado: (2016)

Do we need more patient‐friendly treatment options for overactive bladder (OAB)?
por: Gerig, Nel, et al.
Publicado: (2021)

Sexual dimorphism of detrusor function demonstrated by urodynamic studies in rhesus macaques
por: Biscola, Natalia P., et al.
Publicado: (2020)

Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors
por: Kalil, Jefferson, et al.
Publicado: (2020)

Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report
por: Kato, Taiki, et al.
Publicado: (2021)

Role of detrusor PDGFRα(+) cells in mouse model of cyclophosphamide-induced detrusor overactivity
por: Lee, Haeyeong, et al.
Publicado: (2022)

Coexistent Detrusor Overactivity-Underactivity in Patients with Pelvic Floor Disorders
por: Frigerio, Matteo, et al.
Publicado: (2022)

Psychometric Properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean Population
por: Oh, Seung-June, et al.
Publicado: (2012)

Personalised 3D-Printed Mucoadhesive Gastroretentive Hydrophilic Matrices for Managing Overactive Bladder (OAB)
por: Khizer, Zara, et al.
Publicado: (2023)

Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity
por: Hui, C, et al.
Publicado: (2016)

Autonomous Nervous System Activity in Women with Detrusor Overactivity
por: Im, Hyun Wook, et al.
Publicado: (2010)

Urinary nerve growth factor in patients with detrusor overactivity
por: Korzeniecka-Kozerska, A., et al.
Publicado: (2014)

OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children
por: Austin, Paul F., et al.
Publicado: (2020)

False-negative finding in urodynamic study for the chief complaint. Does it interfere with the clinical outcomes for the treatment of SUI or OAB syndromes?
por: Rodrigues, Paulo, et al.
Publicado: (2020)

Urethral Pressure Measurement as a Tool for the Urodynamic Diagnosis of Detrusor Sphincter Dyssynergia
por: Corona, Lauren E., et al.
Publicado: (2018)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
por: Bellucci, Carlos H.S., et al.
Publicado: (2017)

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
por: Desroziers, Katia, et al.
Publicado: (2013)

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management
por: Turell, Wendy, et al.
Publicado: (2020)

Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB?
por: Gibson, William, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o1bkr3bheuoe41raur0cgojjkr